Uterine sarcomas are rare tumours of mesodermal origin. Malignant change occurring in uterine fibroid is termed as leiomyosarcoma. They constitute around 2-6 % uterine malignancies and 25-36% of uterine sarcomas. The tumour is common in women between the age group 40-50 years. It has an aggressive course & usually metastasis goes to the lungs. The prognosis for women with uterine sarcoma primarily depends on the extent of disease at the time of diagnosis and mitotic index. Women with tumor size >5 cm in maximum diameter have poor prognosis. These tumours should be diagnosed and managed with no delay and must be followed vigilantly as the rate of recurrence & metastasis is very high
Uterine leiomyosarcoma is a rare malignant neoplasm which has a dismal outcome especially when assoc...
Uterine sarcomas are a rare heterogeneous group of tumors of mesenchymal origin, accounting for app...
Endometrial stromal sarcoma (ESS) is uncommon uterine malignant tumor and makes approximately 0.2 % ...
A uterine epithelioid leiomyosarcoma is a rare malignant tumour that arises from the smooth muscle l...
Uterine leiomyosarcoma is a rare malignancy accounting for 1-2% of uterine malignancies with an annu...
Myxoid leiomyosarcoma is an uncommon tumour and in most cases, it is recognised only after the surge...
Uterine leiomyosarcomas are rare aggressive tumors, with high recurrence rates, even when confined t...
Uterine sarcomas are histologically diverse tumours which comprise about 3-7% of uterine malignancie...
Abstract Introduction Malignant change in a leiomyoma or uterine fibroid is termed leiomyosarcoma. I...
Uterine sarcomas are rare soft tissue tumors which constitute 3% to 7% of overall uterine malignanci...
Background: The uterine corpus represents the second most common site for malignancy in the female g...
Fibroid/Leiomyoma is the most common benign tumor of the uterus, arising from uterine smooth muscle....
Uterine sarcomas are an uncommon and heterogeneous group of tumors that account for 3-7% of the mali...
Uterine sarcomas are very unique tumors with mesodermial origin and accounting for 2-6% of uterine c...
Endometrial Stromal Sarcoma (ESS) is a rare slow growing tumour of mesodermal origin arising from th...
Uterine leiomyosarcoma is a rare malignant neoplasm which has a dismal outcome especially when assoc...
Uterine sarcomas are a rare heterogeneous group of tumors of mesenchymal origin, accounting for app...
Endometrial stromal sarcoma (ESS) is uncommon uterine malignant tumor and makes approximately 0.2 % ...
A uterine epithelioid leiomyosarcoma is a rare malignant tumour that arises from the smooth muscle l...
Uterine leiomyosarcoma is a rare malignancy accounting for 1-2% of uterine malignancies with an annu...
Myxoid leiomyosarcoma is an uncommon tumour and in most cases, it is recognised only after the surge...
Uterine leiomyosarcomas are rare aggressive tumors, with high recurrence rates, even when confined t...
Uterine sarcomas are histologically diverse tumours which comprise about 3-7% of uterine malignancie...
Abstract Introduction Malignant change in a leiomyoma or uterine fibroid is termed leiomyosarcoma. I...
Uterine sarcomas are rare soft tissue tumors which constitute 3% to 7% of overall uterine malignanci...
Background: The uterine corpus represents the second most common site for malignancy in the female g...
Fibroid/Leiomyoma is the most common benign tumor of the uterus, arising from uterine smooth muscle....
Uterine sarcomas are an uncommon and heterogeneous group of tumors that account for 3-7% of the mali...
Uterine sarcomas are very unique tumors with mesodermial origin and accounting for 2-6% of uterine c...
Endometrial Stromal Sarcoma (ESS) is a rare slow growing tumour of mesodermal origin arising from th...
Uterine leiomyosarcoma is a rare malignant neoplasm which has a dismal outcome especially when assoc...
Uterine sarcomas are a rare heterogeneous group of tumors of mesenchymal origin, accounting for app...
Endometrial stromal sarcoma (ESS) is uncommon uterine malignant tumor and makes approximately 0.2 % ...